Insider Cluster (2 insiders) ·Filed Jun 12, 2026

LGND

LIGAND PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $189K total
Actionable Insight • Neutral

No actionable signal from these director sales given the trivial dollar amounts relative to market cap. Continue monitoring for any C-suite open-market transactions or cluster buying activity, which would carry stronger informational content.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
LGND ▲ +13.74% at T+60d
NEUTRAL call ✓ call won +13.74% · α vs SPY +12.74% · entry $253.25 → $288.05
Entry anchored
Jun 12, 03:59 PM ET
via exchange tick
T+1d
+0.79%
call +0.79% · α +1.39%
$255.25
settled 4mo ago
T+5d
+3.52%
call +3.52% · α +4.91%
$262.17
settled 3mo ago
T+20d
+22.11%
call +22.11% · α +22.86%
$309.25
settled 3mo ago
T+60d
+13.74%
call +13.74% · α +12.74%
$288.05
settled 23d ago

Price Chart

Loading chart...

Executive Summary

Two directors at Ligand Pharmaceuticals sold a combined ~$1.31M in shares over two days, representing 0.026% of the company's $5.1B market cap. These open-market sales are trivial relative to market cap and likely reflect routine portfolio diversification — no material signal for the stock.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
2

Key Facts

  • Director Aryeh Jason sold 5,000 shares total on June 10-11, 2026 (~$1.25M)
  • Director John L. Lamattina sold 257 shares on June 10, 2026 (~$63.5K)
  • Total insider sales of ~$1.31M represent only 0.026% of LGND's $5.1B market cap
  • All sellers are directors, not C-suite executives — signal weight is lower per academic literature

Financial Impact

Negligible — $1.31M is 0.026% of market cap, well below the 0.1% materiality threshold

none

Risk Factors

  • No material risk identified from this insider activity

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LGND-1781299717319
10 reports for LGND
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +38.85%Apr 14, 2026
Filters
Rows
Reports for LGND — sortable, filterable
TypeNow
Sep 14, 2026
17d ago
Insider Cluster
NEUTRAL ★ 3/10
$276.98 $298.50▲ +7.77%▲ +5.66%$302.99 (+9.39%)
Aug 14, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$291.77 $280.18▼ −3.97%▼ −2.78%$302.99 (+3.85%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$300.14 $288.82▼ −3.77%▼ −4.98%$302.99 (+0.95%)
Jun 25, 2026
14w ago
8-K
MIXED ★ 6/10
$303.59 $319.55▲ +5.26%▲ +3.09%$302.99 (−0.20%)
Jun 18, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$274.88 $295.92▲ +7.65%▲ +9.32%$302.99 (+10.23%)
Jun 16, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$255.25 $279.44▲ +9.48%▲ +11.71%$302.99 (+18.70%)
Jun 12, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$253.25 $262.17▲ +3.52%▲ +4.91%$302.99 (+19.64%)
May 1, 2026
22w ago
Insider Cluster
NEUTRAL ★ 3/10
$227.44 $221.41▼ −2.65%▼ −5.00%$302.99 (+33.22%)
Apr 14, 2026
24w ago
Press Release
BULLISH ★ 8/10
$232.34 $226.67▼ −2.44%▼ −3.83%$302.99 (+30.41%)
Feb 26, 2026
31w ago
8-K
BULLISH ★ 8/10
$196.17 $206.27▲ +5.15%▲ +6.28%$302.99 (+54.45%)
Showing 10 of 10

US Market Status

Market Open — Closes in 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 12, 2026